• 1. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 2. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 3. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 4. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 5. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzyl alcohols

Recent Advances in the Application of (2,6-Dibromo-4-fluorophenyl)methanol (CAS: 1346674-69-8) in Chemical Biology and Pharmaceutical Research

The compound (2,6-Dibromo-4-fluorophenyl)methanol (CAS: 1346674-69-8) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its unique structural properties and potential applications in drug discovery and development. This research brief aims to summarize the latest findings related to this compound, highlighting its synthesis, biological activities, and potential therapeutic uses.

Recent studies have demonstrated that (2,6-Dibromo-4-fluorophenyl)methanol serves as a versatile intermediate in the synthesis of various bioactive molecules. Its halogen-rich structure makes it particularly valuable for the development of novel inhibitors targeting enzymes and receptors involved in critical biological pathways. For instance, researchers have utilized this compound to synthesize potent inhibitors of protein kinases, which play a pivotal role in cancer progression and inflammation.

One of the key advancements in the application of (2,6-Dibromo-4-fluorophenyl)methanol is its role in the development of small-molecule probes for studying protein-ligand interactions. The compound's ability to form stable covalent bonds with target proteins has enabled researchers to design highly specific probes for structural and functional studies. These probes have been instrumental in elucidating the mechanisms of action of various disease-related proteins, paving the way for the design of more effective therapeutics.

In addition to its utility in probe design, (2,6-Dibromo-4-fluorophenyl)methanol has shown promise in the field of medicinal chemistry. Recent preclinical studies have explored its potential as a scaffold for the development of antimicrobial and antiviral agents. The compound's ability to disrupt microbial cell membranes and inhibit viral replication has been demonstrated in vitro, suggesting its potential for further development into clinical candidates.

Despite these promising findings, challenges remain in the optimization of (2,6-Dibromo-4-fluorophenyl)methanol-based compounds for therapeutic use. Issues such as bioavailability, metabolic stability, and off-target effects need to be addressed through further structural modifications and pharmacokinetic studies. Ongoing research is focused on improving the drug-like properties of derivatives derived from this scaffold to enhance their clinical potential.

In conclusion, (2,6-Dibromo-4-fluorophenyl)methanol (CAS: 1346674-69-8) represents a valuable tool in chemical biology and pharmaceutical research. Its diverse applications, ranging from probe design to drug development, underscore its importance in advancing our understanding of biological systems and discovering new therapeutic agents. Future studies will likely continue to explore the full potential of this compound, with the aim of translating its benefits into clinical applications.

• 476620-55-0((2-bromo-4,5-difluorophenyl)methanol)
• 842167-67-3(1-bromo-4-fluoro-2-(methoxymethyl)benzene)
• 1379297-33-2((2-Bromo-4-fluoro-6-methylphenyl)methanol)
• 112108-83-5(2-Bromo-1-(ethoxymethyl)-4-fluorobenzene)
• 261723-33-5((2-Bromo-6-fluorophenyl)methanol)
• 1184915-45-4((2-bromo-3-fluorophenyl)methanol)
• 202865-66-5((2-bromo-5-fluorophenyl)methanol)
• 229027-89-8(2-Bromo-4-fluorobenzyl Alcohol)
• 1251222-82-8(2-broMo-4-fluoro-1-(MethoxyMethyl)benzene)
• 1375069-06-9(2-Bromo-6-fluoro-3-methylbenzyl alcohol)